| Not Yet Recruiting | The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash NCT07179094 | Şule Güzle | N/A |
| Not Yet Recruiting | Fecal Microbiota Transplant for Anorexia Nervosa NCT06593366 | McMaster University | N/A |
| Not Yet Recruiting | Insights Into Participating in Clinical Studies for Anorexia NCT06146075 | Power Life Sciences Inc. | — |
| Completed | Effectiveness of Bacillus Spore Probiotics in Reducing Constipation, Anorexia, and Slow Weight Gain in Childre NCT06154525 | Anabio R&D | N/A |
| Recruiting | Olanzapine for Cancer Related Anorexia-cachexia Syndrome NCT06517199 | Mahidol University | Phase 3 |
| Completed | Anorexia and Personality Traits in Elderly Individuals NCT05418270 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | — |
| Unknown | Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients. NCT05380479 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2 |
| Unknown | Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan) NCT05503147 | Ove Andersen | Phase 1 |
| Unknown | Interoception in Anorexia Nervosa NCT04981626 | Fondation Santé des Étudiants de France | — |
| Active Not Recruiting | Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients NCT04939090 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Olanzapine Anorexia Cachexia NCT05243251 | Cairo University | Phase 3 |
| Withdrawn | Exercise Program in Patients With Anorexia Nervosa (ESATRAL) NCT05039385 | Fundación Universidad Católica de Valencia San Vicente Mártir | N/A |
| Unknown | Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021) NCT04923087 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Adv NCT04803305 | Pfizer | Phase 1 |
| Completed | Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Ner NCT04220112 | University of Minnesota | N/A |
| Completed | Positive Affect Treatment (PAT) to Target Reward Mechanisms in Anorexia Nervosa NCT04007900 | University of Minnesota | N/A |
| Completed | Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Pallia NCT03283488 | University of Sao Paulo | Phase 2 |
| Active Not Recruiting | Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer NCT03637816 | M.D. Anderson Cancer Center | Phase 2 / Phase 3 |
| Completed | Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia NCT04748523 | Instituto Nacional de Cancerologia de Mexico | N/A |
| Unknown | Maudsley Model of Anorexia Nervosa Treatment for Adolescents and Young Adults (MANTR-a) NCT03535714 | Medical University of Vienna | N/A |
| Completed | Adaptive Treatment for Adolescent Anorexia Nervosa NCT03097874 | Stanford University | N/A |
| Completed | Outpatient Treatment of Severe and Enduring Anorexia Nervosa NCT05708404 | Helsinki University Central Hospital | — |
| Terminated | Body Image Disorder in Anorexia Nervosa and Virtual Reality NCT03118921 | University Hospital, Brest | N/A |
| Completed | Representations and Strategies for Recovery NCT03028545 | Hôpital le Vinatier | N/A |
| Unknown | The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cance NCT02619266 | Xinqiao Hospital of Chongqing | Phase 2 / Phase 3 |
| Completed | Estimating the Short-term Effectiveness of Online Advertisements for Improving Health NCT03439553 | Microsoft Research | N/A |
| Completed | Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa NCT02333500 | Fondation Lenval | N/A |
| Completed | Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acut NCT02445378 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients NCT02802540 | Instituto Nacional de Cancerologia de Mexico | Phase 2 / Phase 3 |
| Completed | Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa NCT02148042 | University of Minnesota | — |
| Completed | Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy NCT01941810 | Wake Forest University Health Sciences | N/A |
| Completed | Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-a NCT02050490 | Universitaire Ziekenhuizen KU Leuven | — |
| Withdrawn | Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite NCT01501396 | Washington University School of Medicine | Phase 2 |
| Completed | Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel Toxicity NCT01849107 | Asan Medical Center | N/A |
| Withdrawn | Sensory Workshops and Anorexia Nervosa NCT02793102 | Fondation Lenval | N/A |
| Completed | Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy NCT02830620 | Centre Hospitalier Universitaire de Nice | N/A |
| Unknown | Deep Brain Stimulation and Capsulotomy for the Treatment of Refractory Anorexia Nervosa NCT01678014 | Ruijin Hospital | Phase 1 |
| Completed | Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers NCT01397214 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Unknown | Paullinia Cupana for Anorexia in Oncologic Patients NCT01540019 | Faculdade de Medicina do ABC | Phase 1 / Phase 2 |
| Unknown | Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex NCT01295450 | MDCPharma Produtos Farmaceuticos LTDA | Phase 3 |
| Terminated | Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing R NCT01200602 | Mayo Clinic | Phase 2 |
| Unknown | Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia NCT01206335 | Ohr Pharmaceutical Inc. | Phase 2 |
| Completed | Energy Dense Formula to People Living in Old Peoples Home NCT01259999 | Karolinska University Hospital | N/A |
| Completed | Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study NCT02524301 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | Clinical Diagnosis of Teenagers Admitted to Pediatric Departments NCT00735540 | HaEmek Medical Center, Israel | — |
| Completed | Effects of Resistance Strength Training on Functional Capacity and Well Being of Anorexic Patients NCT00829946 | Universidad Europea de Madrid | N/A |
| Terminated | Haelan and Nutrition in Cancer Patients NCT00558558 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer NCT00535015 | Anaborex | Phase 2 |
| Active Not Recruiting | Effects of Mirtazapine on Appetite in Advanced Cancer Patients NCT00488072 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormaliti NCT00316563 | Alberta Health services | Phase 2 |
| Terminated | Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension NCT00637806 | Par Pharmaceutical, Inc. | Phase 3 |
| Terminated | Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Pati NCT00637728 | Par Pharmaceutical, Inc. | Phase 3 |
| Completed | Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weig NCT00637572 | Endo Pharmaceuticals | Phase 2 |
| Completed | Creatine in Treating Patients With Cancer-Associated Weight Loss NCT00081250 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Unknown | Anorexia in Children With Burn Injury and the Reactions of the Immune and Endocrine Systems NCT00369876 | Sheba Medical Center | — |
| Withdrawn | Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer NCT00425906 | Mayo Clinic | N/A |
| Completed | Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer NCT00046904 | Mayo Clinic | Phase 3 |
| Completed | Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With U NCT00040885 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer NCT00006799 | Wake Forest University Health Sciences | Phase 3 |
| Completed | Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer NCT00031785 | Wake Forest University Health Sciences | Phase 3 |
| Completed | Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Ca NCT00031707 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition NCT00002300 | Bristol-Myers Squibb | Phase 2 |
| Completed | The Safety and Effectiveness of Megace in HIV-Infected Women NCT00002345 | Bristol-Myers Squibb | Phase 4 |
| Completed | A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia NCT00002067 | Bristol-Myers Squibb | Phase 3 |